<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2023-10-26 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities." FDA is issuing this draft guidance to describe how we request and conduct voluntary remote interactive evaluations at facilities where drugs are manufactured, processed, packed, compounded, or held, and at facilities covered under FDA's bioresearch monitoring program. FDA may conside...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-23677</p>
    <p><strong>Publication Date:</strong> 2023-10-26</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/10/26/2023-23677/remote-interactive-evaluations-of-drug-manufacturing-and-bioresearch-monitoring-facilities-draft">https://www.federalregister.gov/documents/2023/10/26/2023-23677/remote-interactive-evaluations-of-drug-manufacturing-and-bioresearch-monitoring-facilities-draft</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-23677</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
